Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00253669
What this trial is testing

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System TumorsThromboembolism
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 110
Large-scale testing (Phase 3)Looking for participantsNCT05029063
What this trial is testing

Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters

Who this might be right for
Venous ThromboembolismCancer
Ottawa Hospital Research Institute 1,828
Testing effectiveness (Phase 2)Study completedNCT03009461
What this trial is testing

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Thrombosis
Peking University 64
Not applicableStudy completedNCT04517461
What this trial is testing

Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery

Who this might be right for
Head and Neck CancerIntraoperative ComplicationsCoagulation Disorder, Blood+4 more
Region Skane 40
Large-scale testing (Phase 3)UnknownNCT03740633
What this trial is testing

Functional Training for the Prevention of Deep Venous Thrombosis

Who this might be right for
Ankle MotionGynecologic NeoplasmDeep Venous Thrombosis+1 more
Lei Li 398
Testing effectiveness (Phase 2)Ended earlyNCT00041782
What this trial is testing

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

Who this might be right for
NeoplasmsDeep Vein Thrombosis
M.D. Anderson Cancer Center 26
Not applicableStudy completedNCT06005883
What this trial is testing

Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring

Who this might be right for
Hepatocellular CarcinomaPortal Vein ThrombosisPrognosis
Keimyung University Dongsan Medical Center 332
Not applicableLooking for participantsNCT06022328
What this trial is testing

Impact of Epigenetic Age on Clinic-biological Presentation and Prognosis in Myeloproliferative Neoplasms Epigenetic Age in Myeloproliferative Neoplasms (EpiC)

Who this might be right for
Myeloproliferative Neoplasm
University Hospital, Bordeaux 120
Post-approval studies (Phase 4)Study completedNCT00966277
What this trial is testing

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Who this might be right for
Pancreatic CancerVenous Thromboembolism
M.D. Anderson Cancer Center 87
Large-scale testing (Phase 3)UnknownNCT03240120
What this trial is testing

Dabigatran Etexilate as Primary Treatment of Malignancy Associated Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisPulmonary Embolism
The University of Hong Kong 99
Not applicableUnknownNCT06061445
What this trial is testing

Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma

Who this might be right for
Stage IIIA Hepatocellular Carcinoma
Fujian Cancer Hospital 22
Large-scale testing (Phase 3)Ended earlyNCT04709380
What this trial is testing

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Who this might be right for
RadiotherapyToripalimabSorafenib+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Not applicableStudy completedNCT05461807
What this trial is testing

An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsVenous ThromboembolismCancer
Bayer 2,437
Not applicableStudy completedNCT05966909
What this trial is testing

Incidence and Clinical Progression of Asymptomatic PICC-Related Thrombosis in Solid Cancer Patients

Who this might be right for
Catheter Related Complication
Azienda Ospedaliera Universitaria Integrata Verona 120
Not applicableUnknownNCT05339581
What this trial is testing

IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation

Who this might be right for
Liver CancerLiver Transplant; ComplicationsHepatocellular Carcinoma+2 more
RenJi Hospital 78
Large-scale testing (Phase 3)Ended earlyNCT05171075
What this trial is testing

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 417
Not applicableStudy completedNCT03965741
What this trial is testing

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners

Who this might be right for
Venous Thromboembolism (VTE)
Bayer 97,765
Not applicableStudy completedNCT00615147
What this trial is testing

Accuracy of the D-Dimer Assay for the Exclusion of Pulmonary Embolism in a High Risk Oncologic Population

Who this might be right for
CancerPulmonary Embolism
Memorial Sloan Kettering Cancer Center 213
Not applicableNot Yet RecruitingNCT06637943
What this trial is testing

Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy

Who this might be right for
Arthritis of KneeArthritis of HipSpine+5 more
Konkuk University Medical Center 210
Next Page